Literature DB >> 21467131

High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.

Hilde P E Peters1, Femke Waanders, Esther Meijer, Jan van den Brand, Eric J Steenbergen, Harry van Goor, Jack F M Wetzels.   

Abstract

BACKGROUND: The variable course of immunoglobulin A nephropathy (IgAN) warrants accurate tools for the prediction of progression. Urinary kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) are markers for the detection of early tubular damage caused by various renal conditions. We evaluated the prognostic value of these markers in patients with IgAN.
METHODS: We included patients (n = 65, 72% male, age 43 ± 13 years) with biopsy-proven IgAN, who were evaluated for proteinuria. Urinary KIM-1 and NGAL were measured by enzyme-linked immunosorbent assay. We analysed data using Cox regression for the outcome end-stage renal disease (ESRD).
RESULTS: Median serum creatinine was 142 μmol/L and proteinuria 2.2 g/day. During follow-up (median 75 months), 23 patients (35%) developed ESRD. In patients with IgAN median urinary KIM-1 excretion was 1.7 ng/min and NGAL excretion was 47 ng/min, both significantly higher than in healthy controls. KIM-1 and NGAL were correlated with proteinuria (r = 0.40 and 0.34, respectively, P < 0.01) and each other (r = 0.53, P < 0.01) but not with estimated glomerular filtration rate (eGFR). Interestingly, KIM-1 was not significantly correlated with the excretion of α(1)-microglobulin (α(1)m) and β(2)-microglobulin (β(2)m), known markers of tubular injury. Univariate analysis showed that baseline serum creatinine and urinary excretion of total protein, α(1)m, β(2)m, immunoglobulin G, KIM-1 and NGAL were significantly associated with ESRD. By multivariate analysis, serum creatinine and KIM-1 excretion proved to be significant independent predictors of ESRD.
CONCLUSION: KIM-1 and NGAL excretion are increased in patients with IgAN and correlate with proteinuria but not with eGFR. Baseline serum creatinine and urinary KIM-1, but not proteinuria, are independent predictors of ESRD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467131     DOI: 10.1093/ndt/gfr135

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  29 in total

Review 1.  Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Authors:  Salvador Lopez-Giacoman; Magdalena Madero
Journal:  World J Nephrol       Date:  2015-02-06

Review 2.  Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Authors:  Margaret Colleen Hastings; Zina Moldoveanu; Hitoshi Suzuki; Francois Berthoux; Bruce A Julian; John T Sanders; Matthew B Renfrow; Jan Novak; Robert J Wyatt
Journal:  Expert Opin Med Diagn       Date:  2013-11

3.  Structural equation modeling highlights the potential of Kim-1 as a biomarker for chronic kidney disease.

Authors:  Lesley Gardiner; Adebayo Akintola; Gang Chen; Jeffrey M Catania; Vishal Vaidya; Robert C Burghardt; Joseph V Bonventre; Jerome Trzeciakowski; Alan R Parrish
Journal:  Am J Nephrol       Date:  2012-01-20       Impact factor: 3.754

4.  The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.

Authors:  Helen V Alderson; James P Ritchie; Sabrina Pagano; Rachel J Middleton; Menno Pruijm; Nicolas Vuilleumier; Philip A Kalra
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-16       Impact factor: 8.237

5.  Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy.

Authors:  Pei Chen; Guizhen Yu; Xue Zhang; Xinfang Xie; Jinwei Wang; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 8.237

6.  Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Authors:  Min Tao; Yingfeng Shi; Lunxian Tang; Yi Wang; Lu Fang; Wei Jiang; Tao Lin; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

7.  Glomerular and tubular damage markers in individuals with progressive albuminuria.

Authors:  Ferdau L Nauta; Lieneke Scheven; Esther Meijer; Wim van Oeveren; Paul E de Jong; Stephan J L Bakker; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

Review 8.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

9.  KIM-1 expression predicts renal outcomes in IgA nephropathy.

Authors:  Soon Hyo Kwon; Moo Yong Park; Jin Seok Jeon; Hyunjin Noh; Soo Jeong Choi; Jin Kuk Kim; Seung Duk Hwang; So Young Jin; Dong Cheol Han
Journal:  Clin Exp Nephrol       Date:  2012-11-08       Impact factor: 2.801

10.  Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy.

Authors:  Kojiro Nagai; Masashi Miyoshi; Takei Kake; Naoshi Fukushima; Motokazu Matsuura; Eriko Shibata; Satoshi Yamada; Kazuhiro Yoshikawa; Hiro-Omi Kanayama; Tomoya Fukawa; Kunihisa Yamaguchi; Hirofumi Izaki; Akira Mima; Naoko Abe; Toshikazu Araoka; Taichi Murakami; Fumi Kishi; Seiji Kishi; Tatsuya Tominaga; Tatsumi Moriya; Hideharu Abe; Toshio Doi
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.